Significant improvements on insulin sensitivity, glucose intolerance, and hepatic glucose production as well as fasting hyperglycemia were observed after 10 weeks post AAV8-RIMKLA injection (Supplementary Fig. 3d–g). The gene discussed is INS; the disease is Hyperglycemia.